Longitudinal neuroimaging and neurocognitive assessment of risk and protective factors across the schizophrenia spectrum
Longitudinal neuroimaging and neurocognitive assessment of risk and protective factors across the schizophrenia spectrum
批准号:
10542376
负责人:
ERIN A. HAZLETT
金额:
$100.32万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-03-06 至 2024-12-31
关键词:
AgeAntipsychotic AgentsAttenuatedBrainBrain regionBrodmann&aposs areaClinicalClinical assessmentsCognitionCognitive deficitsCoupledDataDeteriorationDiagnosisDiagnosticDiffusion Magnetic Resonance ImagingDiseaseEtiologyEventFunctional Magnetic Resonance ImagingGeneticGoalsHospitalizationImpairmentIndividualInvestigationLinkLongitudinal StudiesMachine LearningMagnetic Resonance ImagingMeasuresModelingNeurobiologyNeurocognitionNeurocognitiveNeuropsychologyOnset of illnessOutcomePathogenesisPatientsPatternPerformancePersonality DisordersPharmaceutical PreparationsPhenotypePrefrontal CortexPsychosesResearch Domain CriteriaRestRiskRisk AssessmentRisk FactorsScanningSchizophreniaSchizotypal Personality DisorderSeveritiesShort-Term MemoryStructureSymptomsTemporal LobeTestingTimeTreatment Factorcausal modelearly onsetfollow-upfrontal lobefunctional outcomesimprovedlongitudinal courselongitudinal designmorphogensmultimodal neuroimagingmultimodalityneural circuitneuroimagingnon-verbalnovel strategiespredictive modelingprotective factorspsychoticresilienceschizophrenia spectrum disordersocial deficitswhite matter
中文摘要
项目总结
分裂型人格障碍(SPD)与精神分裂症(SZ)相似,但数量较少,程度较轻
异常,因此代表了一个重要但未被充分研究的中间SZ谱表型。
对SPD异常的检查将提供有关病因、遗传学、治疗和风险的信息。
与精神病有关的因素。尽管SPD患者表现出明显的颞叶
类似于SZ的异常,我们假设
额叶(例如,背外侧前额叶皮质)可以保护这些人免受坦率的精神病和
严重的社会和认知缺陷通常在深圳观察到。研究SPD是一种强大的抗精神病药物
在深圳观察到的用药和住院混淆并不存在。此外,也没有研究
检查SZ谱中的神经生物学变化,该谱结合了SPD患者
这里提出的纵向设计。这一新的方法将有助于理清潜在的风险和保护
SZ谱系中的精神病因素。这是第一次利用多模式磁共振成像进行纵向研究。
和研究领域标准(RDoC)方法在SZ谱系障碍中识别异常神经
从健康对照组(HCS)到SPD再到SZ的连续回路,并检查这些指标的变化
与症状严重程度、神经认知和功能结果的损害有关。我们建议
研究了三组(每组80人)的人口统计匹配和严格诊断的个人(18岁-
40):HCS(无轴心I或人格障碍),未服药的SPD患者(无轴心I障碍),以及
基线、9个月和18个月随访的早发性(患病头2年)SZ患者。措施评估
额叶和颞叶的完整性包括多模式磁共振成像(结构MRI、DTI、静息状态fMRI和
基于任务的功能磁共振成像,采用非语言事件相关工作记忆任务;基线和18个月)和
神经心理评估(所有三个时间点)。我们将利用动态因果模型来测试
相互竞争的神经生物学模型涉及SZ频谱中异常的额颞部连接和
集成多模式神经成像、神经认知和临床评估的机器学习方法
数据。本研究的主要目的有三:(1)研究额-颞叶/环路的纵向运动过程
应用多模式磁共振成像研究SZ谱的异常;(2)研究SZ谱的纵向过程
SZ谱中的神经认知、临床和功能结果;(3)决定哪种因素或组合
的因素来区分SZ谱中的群体,以识别那些与罹患和
使用机器学习保护SZ。
英文摘要
PROJECT SUMMARY
Schizotypal personality disorder (SPD) is similar to schizophrenia (SZ), but with fewer and attenuated
abnormalities, thus representing an important yet understudied intermediate SZ-spectrum phenotype.
Examination of abnormalities in SPD will provide information regarding etiology, genetics, treatment and risk
factors associated with psychosis. Although individuals with SPD demonstrate marked temporal lobe
abnormalities that resemble SZ, we hypothesize that relative “sparing” or “functional enhancement” in the
frontal lobes (e.g., dorsolateral prefrontal cortex), may protect these individuals from frank psychosis and the
severe social and cognitive deficits typically observed in SZ. Studying SPD is powerful as antipsychotic
medication and hospitalization confounds observed in SZ are not present. Moreover, there is no study
examining neurobiological changes in the SZ-spectrum that incorporates individuals with SPD using a
longitudinal design as proposed here. This novel approach will help disentangle potential risk and protective
factors for psychosis in the SZ spectrum. This is the first longitudinal study to utilize multimodal MR imaging
and Research Domain Criteria (RDoC) approaches in SZ-spectrum disorders to identify aberrant neural
circuitry along a continuum from healthy controls (HCs) to SPD to SZ and examine changes in these measures
in relationship to impairments in symptom severity, neurocognition and functional outcome. We propose
studying three groups (80 in each) of demographically matched and rigorously diagnosed individuals (age 18-
40): HCs (no Axis I or personality disorder), unmedicated individuals with SPD (and no Axis I disorder), and
early-onset (first 2 years of illness) SZ patients at baseline, 9-, and 18-month follow-up. Measures assessing
frontal and temporal lobe integrity include multimodal MR imaging (structural MRI, DTI, resting-state fMRI, and
task-based fMRI with a nonverbal event related working-memory task; baseline and 18-months) and
neuropsychological assessment (all three timepoints). We will utilize dynamic causal modeling to test
competing neurobiological models involving abnormal frontotemporal connectivity in the SZ-spectrum and
machine learning approaches to integrate multimodal neuroimaging, neurocognitive, and clinical assessment
data. We focus on three specific aims: (1) Investigate the longitudinal course of frontal-temporal lobe/circuitry
abnormalities in the SZ-spectrum using multimodal MR imaging; (2) Investigate the longitudinal course of
neurocognition, clinical, and functional outcome in the SZ spectrum; (3) Determine which factor or combination
of factors differentiate groups in the SZ-spectrum to identify those that are associated with risk for and
protection from SZ using machine learning.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CSRD Research Career Scientist Award Application
-
批准号:10701136
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:ERIN A. HAZLETT
-
依托单位:
A Novel Cognitive Remediation Intervention Targeting Poor Decision-Making and Depression in Veterans at High Risk for Suicide: A Safe,Telehealth Approach During the COVID-19 Pandemic
-
批准号:10366431
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:ERIN A. HAZLETT
-
依托单位:
A Novel Cognitive Remediation Intervention Targeting Poor Decision-Making and Depression in Veterans at High Risk for Suicide: A Safe,Telehealth Approach During the COVID-19 Pandemic
-
批准号:10539275
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:ERIN A. HAZLETT
-
依托单位:
Longitudinal neuroimaging and neurocognitive assessment of risk and protective factors across the schizophrenia spectrum
-
批准号:10381940
-
项目类别:
-
资助金额:$20.68万
-
财政年份:2020
-
负责人:ERIN A. HAZLETT
-
依托单位:
Longitudinal neuroimaging and neurocognitive assessment of risk and protective factors across the schizophrenia spectrum
-
批准号:10319171
-
项目类别:
-
资助金额:$99.89万
-
财政年份:2020
-
负责人:ERIN A. HAZLETT
-
依托单位:
CSR&D Research Career Scientist Award Application
-
批准号:10177966
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:ERIN A. HAZLETT
-
依托单位:
CSR&D Research Career Scientist Award Application
-
批准号:10426091
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:ERIN A. HAZLETT
-
依托单位:
CSR&D Research Career Scientist Award Application
-
批准号:9892965
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:ERIN A. HAZLETT
-
依托单位:
CSR&D Research Career Scientist Award Application
-
批准号:9551820
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:ERIN A. HAZLETT
-
依托单位:
Neurobiology of Affective Instability in Veterans at Low and High Risk for Suicide
-
批准号:10311973
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:ERIN A. HAZLETT
-
依托单位:
Neurobiology of Affective Instability in Veterans at Low and High Risk for Suicide
-
批准号:9892959
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:ERIN A. HAZLETT
-
依托单位:
Selecting Best Neuroleptic Treatment for Veterans with Schizophrenia
-
批准号:8392955
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:ERIN A. HAZLETT
-
依托单位:
Selecting Best Neuroleptic Treatment for Veterans with Schizophrenia
-
批准号:8142659
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:ERIN A. HAZLETT
-
依托单位:
Selecting Best Neuroleptic Treatment for Veterans with Schizophrenia
-
批准号:8277786
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:ERIN A. HAZLETT
-
依托单位:
NEURAL SUBSTRATES OF EMOTION IN BORDERLINE PATIENTS
-
批准号:7953684
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2009
-
负责人:ERIN A. HAZLETT
-
依托单位:
NEURAL SUBSTRATES OF EMOTION IN BORDERLINE PATIENTS
-
批准号:7718165
-
项目类别:
-
资助金额:$2.05万
-
财政年份:2008
-
负责人:ERIN A. HAZLETT
-
依托单位:
NEURAL SUBSTRATES OF EMOTION REGULATION IN HEALTHY INDIVIDUALS
-
批准号:7718192
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2008
-
负责人:ERIN A. HAZLETT
-
依托单位:
NEURAL SUBSTRATES OF EMOTION IN BORDERLINE PATIENTS
-
批准号:7605350
-
项目类别:
-
资助金额:$2.61万
-
财政年份:2007
-
负责人:ERIN A. HAZLETT
-
依托单位:
Neural Substrates of Emotion in Borderline Patients
-
批准号:7342829
-
项目类别:
-
资助金额:$37.03万
-
财政年份:2006
-
负责人:ERIN A. HAZLETT
-
依托单位:
Neural Substrates of Emotion in Borderline Patients
-
批准号:7171852
-
项目类别:
-
资助金额:$37.03万
-
财政年份:2006
-
负责人:ERIN A. HAZLETT
-
依托单位:
海外基金